Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA

被引:587
作者
Ryo, A
Suizu, F
Yoshida, Y
Perrem, K
Liou, YC
Wulf, G
Rottapel, R
Yamaoka, S
Lu, KP
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Biol Program,Div Hematol Oncol,Dept Med, Boston, MA 02215 USA
[2] Yokohama City Univ, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[3] Univ Occupat & Environm Hlth, Dept Immunol, Yahata Nishi Ku, Fukuoka 8078555, Japan
[4] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada
[5] Tokyo Med & Dent Univ, Dept Mol Virol, Bunkyo Ku, Tokyo 1138519, Japan
关键词
D O I
10.1016/S1097-2765(03)00490-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor NF-kappaB is activated by the degradation of its inhibitor IB, resulting in its nuclear translocation. However, the mechanism by which nuclear NF-kappaB is subsequently regulated is not clear. Here we demonstrate that NF-kappaB function is regulated by Pin1-mediated prolyl isomerization and ubiquitin-mediated proteolysis of its p65/RelA subunit. Upon cytokine treatment, Pin1 binds to the pThr254-Pro motif in p65 and inhibits p65 binding to IkappaBalpha, resulting in increased nuclear accumulation and protein stability of p65 and enhanced NF-kappaB activity. Significantly, Pin1-deficient mice and cells are refractory to NF-kappaB activation by cytokine signals. Moreover, the stability of p65 is controlled by ubiquitin-mediated proteolysis, facilitated by a cytokine signal inhibitor, SOCS-1, acting as a ubiquitin ligase. These findings uncover two important mechanisms of regulating NF-kappaB signaling and offer new insight into the pathogenesis and treatment of some human diseases such as cancers.
引用
收藏
页码:1413 / 1426
页数:14
相关论文
共 44 条
  • [1] AYALA G, 2003, CANCER RES, V4, P175
  • [2] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
    Baldwin, AS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) : 241 - 246
  • [3] The Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β
    Bannerman, DD
    Tupper, JC
    Kelly, JD
    Winn, RK
    Harlan, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) : 419 - 425
  • [4] EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B
    BEG, AA
    SHA, WC
    BRONSON, RT
    GHOSH, S
    BALTIMORE, D
    [J]. NATURE, 1995, 376 (6536) : 167 - 170
  • [5] Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells
    Bhat-Nakshatri, P
    Sweeney, CJ
    Nakshatri, H
    [J]. ONCOGENE, 2002, 21 (13) : 2066 - 2078
  • [6] Nuclear Factor-KB (NF-KB) regulates proliferation and branching in mouse mammary epithelium
    Brantley, DM
    Chen, CL
    Muraoka, RS
    Bushdid, PB
    Bradberry, JL
    Kittrell, F
    Medina, D
    Matrisian, LA
    Kerr, LD
    Yull, FE
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) : 1445 - 1455
  • [7] IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
    Cao, YX
    Bonizzi, G
    Seagroves, TN
    Greten, FR
    Johnson, R
    Schmidt, EV
    Karin, M
    [J]. CELL, 2001, 107 (06) : 763 - 775
  • [8] Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy
    Chaisson, ML
    Brooling, JT
    Ladiges, W
    Tsai, S
    Fausto, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (02) : 193 - 202
  • [9] Duration of nuclear NF-κB action regulated by reversible acetylation
    Chen, LF
    Fischle, W
    Verdin, E
    Greene, WC
    [J]. SCIENCE, 2001, 293 (5535) : 1653 - 1657
  • [10] DADD CA, 1993, BIOTECHNIQUES, V14, P266